A novel in‐frame deletion in KIF5C gene causes infantile onset epilepsy and psychomotor retardation

Santasree Banerjee, Qiang Zhao, Bo Wang, Jiale Qin, Xin Yuan, Ziwei Lou, Weizeng Zheng, Huanguo Li, Xiaojun Wang, Xiawei Cheng, Yu Zhu, Fan Lin, Fan Yang, Junyu Xu, Anjana Munshi, Parimal Das, Yuanfeng Zhou, Kausik Mandal, Yi Wang, Muhammad Ayub, Nobutaka Hirokawa, Yongmei Xi, Guangfu Chen, Chen LiMedComm 2024 · DOI

TL;DR

Researchers have identified a novel genetic mutation in the KIF5C gene that causes severe infantile-onset epilepsy and psychomotor retardation in a young boy. This discovery highlights the critical role of KIF5C in brain development and offers potential for improved diagnosis and management of similar neurodevelopmental disorders.

What Problem Does This Paper Address?

Intellectual disability (ID) and developmental delay (DD) are significant health concerns, affecting a substantial portion of children worldwide. While genetic factors are known to be a major cause, the specific genetic basis for many cases remains elusive. Kinesin superfamily (KIF) proteins are crucial for intracellular transport within neurons, playing vital roles in brain development and plasticity. Previous studies have hinted at KIF genes' involvement in neurodevelopmental disorders, but specific gene-disease associations, particularly for KIF5C, and the underlying molecular mechanisms were not fully understood. This paper addresses the challenge of identifying the genetic cause of severe DD/ID in a young patient with epilepsy and psychomotor retardation, and to elucidate the functional consequences of any identified genetic variant.

Methods

The study employed a multi-pronged approach:

  • Whole Exome Sequencing (WES): This standard technique was used to identify genetic variations in the patient's DNA.
  • Sanger Sequencing: Used to confirm the WES findings and to verify the absence of the identified variant in the patient's parents and family members, establishing it as a de novo mutation.
  • In vitro ATPase Activity Assays: Recombinant KIF5C proteins (wild-type and mutant) were expressed and purified to measure their ATP hydrolysis activity, a key function of motor proteins.
  • Immunofluorescence Microscopy: Used to visualize the localization of wild-type and mutant KIF5C proteins within cells, comparing their distribution to cellular structures like microtubules.
  • Live-cell Imaging: Employed to observe the dynamic behavior of cells expressing wild-type and mutant KIF5C, particularly focusing on cell morphology and migration.
  • Artificial Cargo Trafficking Assay: A sophisticated assay using rapamycin-inducible dimerization was used to track the movement of peroxisomes (as artificial cargo) by KIF5C proteins in cells.
  • Drosophila melanogaster Models: The fruit fly was used as a model organism to study the developmental and lethal effects of the KIF5C variant by creating transgenic flies with altered KHC (the Drosophila homolog of KIF5C) expression.
  • Homology Modeling and Molecular Docking: Computational methods were used to predict how the identified mutation might affect the structure and ATP-binding capabilities of the KIF5C protein.

Datasets

  • Patient Genomic Data: Whole exome sequencing data from the proband.
  • Family Member DNA: Samples from parents and a younger sister for Sanger sequencing validation.
  • Control DNA: Samples from 100 normal individuals of the same ethnicity for variant validation.
  • Public Databases: Online Mendelian Inheritance in Man (OMIM), Human Genome Mutation Database (HGMD), Genome Aggregation Database (gnomAD), Leiden Open Variation Database (LOVD), Exome Aggregation Consortium (ExAC), NCBI dbSNP, ClinVar, International HapMap project, and 1000 Genome Database were used for variant annotation and filtering.
  • Protein Structure Databases: PDB ID: 3J8Y (KIF5B crystal structure) was used as a template for homology modeling.

Key Insights and Ideas

  • KIF5C's ATP-binding domain is crucial for neurodevelopment: While previous KIF5C variants were linked to the microtubule-binding domain, this study identifies a variant within the ATP-binding domain, suggesting this region is also critical for normal brain function.
  • A specific deletion causes significant functional impairment: The novel in-frame deletion (c.265_267delTCA) leading to the loss of p.Ser90 results in a dramatically reduced ATPase activity and altered protein localization.
  • Motor protein dysfunction impacts cell migration and cargo transport: The mutation not only affects the motor protein's intrinsic function but also impairs cell migration and the ability to transport essential cargo like peroxisomes.
  • Drosophila models confirm the severity of the mutation: Overexpression of the mutated KHC in Drosophila neurons leads to developmental defects and lethality, strongly supporting the variant's pathogenic role.
  • Expanding the spectrum of KIF5C-related disorders: This study identifies a new type of mutation (in-frame deletion) in KIF5C and links it to a severe neurodevelopmental phenotype, broadening our understanding of KIF5C's role in human health.

Key Results

  • Identification of a novel de novo KIF5C variant: A heterozygous in-frame deletion (c.265_267delTCA) in exon 3 of KIF5C was found in the proband, resulting in the loss of the evolutionarily conserved p.Ser90 residue.
  • Reduced ATPase activity: In vitro assays showed a significant reduction in the ATP hydrolysis activity of the mutant KIF5C protein compared to wild-type.
  • Altered protein localization and cell morphology: Mutant KIF5C colocalized with microtubules and showed impaired cytoplasmic distribution, leading to altered cell morphology and reduced cell motility.
  • Defective cargo transport: Live-cell imaging demonstrated that the mutant KIF5C lost its ability to transport peroxisomes effectively.
  • Developmental defects and lethality in Drosophila: Overexpression of the mutated KHC in Drosophila neurons caused visible wing phenotypes, loss of locomotion, and reduced survival rates.
  • Clinical phenotype: The patient presented with severe infantile-onset epilepsy, intellectual disability, brain atrophy, and psychomotor retardation.

Limitations and Future Work

  • Limited patient cohort: The study focuses on a single patient, which, while providing a strong case, limits generalizability. The authors suggest that identifying more patients with KIF5C variants across different ethnicities will expand the understanding of its role in DD/ID.
  • In vitro and model system limitations: While the functional studies in cell lines and Drosophila provide strong evidence, they are models and may not perfectly recapitulate the complex human neurodevelopmental environment.
  • Uncertain significance variants: The study mentions finding other variants of uncertain significance, which were not pursued further. Future work could explore these to see if they contribute to the phenotype or other conditions.
  • Mechanism of neuronal migration impairment: While the study shows altered cell migration, the precise molecular mechanisms by which KIF5C variants disrupt neuronal migration in the developing brain require further investigation.
  • Therapeutic implications: The paper suggests that understanding the role of KIF5C in intracellular transport could lead to more timely and accurate diagnosis and disease management. Future research could explore potential therapeutic strategies targeting KIF5C function or downstream pathways.

Summary updated

Abstract

Motor proteins, encoded by Kinesin superfamily (<i>KIF</i>) genes, are critical for brain development and plasticity. Increasing studies reported <i>KIF</i>'s roles in neurodevelopmental disorders. Here, a 6 years and 3 months-old Chinese boy with markedly symptomatic epilepsy, intellectual disability, brain atrophy, and psychomotor retardation was investigated. His parents and younger sister were phenotypically normal and had no disease-related family history. Whole exome sequencing identified a novel heterozygous <i>in-frame</i> deletion (c.265_267delTCA) in exon 3 of the <i>KIF5C</i> in the proband, resulting in the removal of evolutionarily highly conserved p.Ser90, located in its ATP-binding domain. Sanger sequencing excluded the proband's parents and family members from harboring this variant. The activity of ATP hydrolysis in vitro was significantly reduced as predicted. Immunofluorescence studies showed wild-type KIF5C was widely distributed throughout the cytoplasm, while mutant KIF5C was colocalized with microtubules. The live-cell imaging of the cargo-trafficking assay revealed that mutant KIF5C lost the peroxisome-transporting ability. <i>Drosophila</i> models also confirmed p.Ser90del's essential role in nervous system development. This study emphasized the importance of the <i>KIF5C</i> gene in intracellular cargo-transport as well as germline variants that lead to neurodevelopmental disorders and might enable clinicians for timely and accurate diagnosis and disease management in the future.
BibTeX
@inproceedings{banerjee2024novel,
  author = {Santasree Banerjee and Qiang Zhao and Bo Wang and Jiale Qin and Xin Yuan and Ziwei Lou and Weizeng Zheng and Huanguo Li and Xiaojun Wang and Xiawei Cheng and Yu Zhu and Fan Lin and Fan Yang and Junyu Xu and Anjana Munshi and Parimal Das and Yuanfeng Zhou and Kausik Mandal and Yi Wang and Muhammad Ayub and Nobutaka Hirokawa and Yongmei Xi and Guangfu Chen and Chen Li},
  title = {{A novel in‐frame deletion in KIF5C gene causes infantile onset epilepsy and psychomotor retardation}},
  booktitle = {MedComm},
  year = {2024},
  doi = {10.1002/mco2.469},
}
Figure